Resistant diabetic macular edema may necessitate transitioning from one intravitreal pharmacotherapy to another when the edema is persistent — a practice sometimes undertaken in clinical management.
Can Diabetic Macular Edema (DME) Be Prevented? What to Know About Early Detection and Risk Reduction
DME is a diabetes complication that threatens your the clarity of your vision. But managing blood sugar, blood pressure, and ...
People with diabetic macular edema may receive eye injections to help control their symptoms. These shots can help to improve vision and also stop the damage that causes vision issues to get worse.
Diabetic macular edema (DME) is a diabetes complication that can cause low vision or vision loss. Early treatment may help preserve vision longer. High blood sugar can damage tiny eye blood vessels, ...
Joseph M. Coney, MD, FACS, reviews best practices for improving adherence to treatment among patients with diabetic macular edema through comprehensive education on the disease and available therapies ...
Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...
People with diabetic macular edema may get eye injections to help control their symptoms. These eye injections can improve vision and also stop the damage that causes vision to get worse. Most of ...
Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
Diabetic macular edema (DME) occurs when fluid accumulates behind the macula, the part of your retina that processes central vision. DME can occur at any stage of diabetic retinopathy (DR). However, ...
You may think diabetic macular edema (DME) affects older people only. But the truth is, the eye condition can develop in anyone with type 1 or type 2 diabetes. DME is more common in people with type 2 ...
According to the phase II/III DIAMOND trial, there was early evidence of efficacy for OCS-01 eye drops in patients with diabetic macular edema (DME) compared with sham. The findings were reported at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results